CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
NASDAQ · Healthcare · Biotechnology · SG
$3.16
+7.48%Margins
Gross margin
-1.3%
EBITDA margin
-9137.1%
EBIT margin
-9154.6%
Net margin
-9366.8%
FCF margin
—
-92.4%
Return on equity
-55.0%
Return on assets
-82.5%
Return on invested capital
0.01x
Asset turnover
-$7.2M
Cash from operations
$0.92
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025